glp-1 drugs semaglutide Diabetes Patients Also Struggle to Access Agonists A Guide to GLP-1s: Resources

However, ongoing digestive discomfort may affect eating habits, so managing symptoms can help you stay comfortable throughout treatment

Community protocols on TRT describe: CJC-1295 (no DAC): 100 mcg subcutaneous, 2-3x daily (pre-bed dose described as most important) CJC-1295 (with DAC): 2 mg subcutaneous, 1-2x per week Starting after the TRT protocol is stable (8+ weeks) Monitoring IGF-1 at the 4-week and 12-week marks For reconstitution and detailed protocols, see our CJC-1295 dosing guide and CJC-1295 DAC dosing guide

LIMITING FACTORS Researchers cautioned that nearly all of the data presented were from observational studies, raising the risk of confounding factors

13 Fourteen states cover GLP-1s for obesity under Medicaid